NKTR Nektar Therapeutics - Common Stock
$75,92
Harga · Agu 19, 2026
Fundamental per Agu 14, 2026
Rentang 52M
$25–$109
60% of range
Peringkat Analis
BUY
17 analysts
Target Harga
$153
+102% upside
P/E (TTM)
-11.3
ROE
-500.1%
Margin Laba Bersih
-297.1%
Tentang Nektar Therapeutics - Common Stock Tinjauan perusahaan dari Wikipedia
Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.
Baca selengkapnya
Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, etc. The company developed the world's first inhalable non-injectable insulin, Exubera, which was awarded as the bronze award by Wall Street Journal for its technological breakthrough.
Background
The company is engaged in developing a proprietary pipeline of drug candidates for several therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology. The company's research and development involve in small molecule and biologic drug candidates. Its drug candidate base consists of naloxegol (Movantik), a Phase III oral opioid antagonist, etirinotecan pegol, a topoisomerase inhibitor under Phase III clinical study as of 2012, NKTR 061, NKTR-181, NKTR-214, etc.
In 2013, the company was assigned a patent which was developed by the company and other four co-inventors. The products of the company is served as a supplement to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability and other areas of drugs for the patients worldwide. As of March 2014, the company had a market capitalization of $1.7 billion with an enterprise value of $1.67 billion.
As of December 2024, at a stock price-per-share of roughly $1, the market cap is roughly $171 million. Nektar underwent periods of downsizing after unsuccessful partnerships were ended with Eli Lilly in 2023 and Bristol Myers Squibb in 2022, resulting in layoffs of most company employees.
Pipeline
Etirinotecan pegol was in the phase III BEACON trial as well as in the I-SPY2 adaptive clinical trial for breast cancer in 2016. The European Medicines Agency refused a marketing authorisation in 2017.
Bempegaldesleukin (NKTR-214) is a CD122-biased immune-stimulatory cytokine, Phase I results were announced in November 2016. It is now in a phase 2 trial in combination with nivolumab for various advanced cancers.
In 2023 Nektar's partnership with Eli Lilly in development of "rezpeg" was ended. Eli Lilly claimed the drug lacked suitable efficacy, while Nektar responded that Eli Lilly had botched the analysis.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
NKTR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$75.92
Kapitalisasi Pasar
$2.24B
P/E (TTM)
-11.3
EPS (TTM)
$-9.73
Pendapatan (TTM)
$55M
Imbal Hasil Dividen
—
ROE
-500.1%
D/E Utang/Ekuitas
—
Rentang 52M
$25 – $109
NKTR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$55M
2016-12-31
→
2025-12-31
EPS
$-9.73
2016-12-31
→
2025-12-31
Arus Kas Bebas
$-209M
2016-12-31
→
2025-12-31
Margin
-297.1%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
NKTR
Median Rekan
P/E (TTM)
-11.3
29.4
P/S (TTM)
40.5
4.9
P/B
24.9
6.5
Price / FCF (Harga / FCF)
-10.7
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
NKTR
Median Rekan
Operating Margin (Margin Operasi)
-253.7%
—
Net Profit Margin (Margin Laba Bersih)
-297.1%
-9.0%
ROA
-56.2%
-8.2%
ROE
-500.1%
-19.4%
ROIC
-155.8%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
NKTR
Median Rekan
Current Ratio (Rasio Lancar)
5.0
3.6
Quick Ratio (Rasio Cepat)
0.3
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
NKTR
Median Rekan
Revenue YoY (Pendapatan YoY)
-43.9%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
-15.7%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
-18.4%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
NKTR
Median Rekan
NKTR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
17 analis
- Beli Kuat 7 41,2%
- Beli 8 47,1%
- Tahan 2 11,8%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
9 analis · 2026-08-16
Median
$151.00
← Di bawah semua target
$75.92
Rendah
$80.00
Tinggi
$192.00
Target median
$151.00
+98,9%
Target rata-rata
$153.22
+101,8%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.21%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-1.23 | $-2.02 | 0.79% |
| 31 Maret 2026 | $-1.82 | $-1.63 | -0.19% |
| 31 Des. 2025 | $-1.78 | $-2.52 | 0.74% |
| 30 Sep. 2025 | $-1.87 | $-2.74 | 0.87% |
| 30 Juni 2025 | $-2.95 | $-3.10 | 0.15% |
| 31 Maret 2025 | $-3.60 | $-2.51 | -1.1% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| RAPP | $1.45B | -10.6 | — | — | -29.8% | — |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 17
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55M | $98M | $90M | $92M | $102M | $153M | $115M | $1.19B | $308M | $165M | $231M | $201M | |
| Cost of Revenue | $0 | $31M | $34M | $22M | $25M | $19M | $21M | $24M | $31M | $30M | $34M | $29M | |
| R&D Expense | $117M | $121M | $114M | $218M | $400M | $409M | $435M | $400M | $268M | $204M | $183M | $148M | |
| SG&A Expense | $69M | $77M | $77M | $92M | $123M | $105M | $99M | $81M | $52M | $44M | $43M | $41M | |
| Operating Expenses | $195M | $204M | $354M | $468M | $548M | $578M | $555M | $505M | $367M | $278M | $260M | $217M | |
| Operating Income | $-140M | $-105M | $-264M | $-376M | $-446M | $-425M | $-440M | $688M | $-60M | $-113M | $-29M | $-16M | |
| Interest Expense | · | · | · | $0 | $0 | $7M | $21M | $22M | $22M | $22M | $18M | $18M | |
| Interest Income | $10M | $14M | $19M | $7M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $361.0K | $-390.0K | $-6M | $-116.0K | $-162.0K | $18M | $46M | $38M | $5M | $2M | $2M | $814.0K | |
| Pretax Income | $-164M | $-119M | $-276M | $-365M | $-523M | $-444M | $-440M | $683M | $-96M | $-153M | $-81M | $-54M | |
| Income Tax | $-138.0K | $-239.0K | $-200.0K | $3M | $557.0K | $493.0K | $613.0K | $1M | $616.0K | $876.0K | $506.0K | $-512.0K | |
| Net Income | $-164M | $-119M | $-276M | $-368M | $-524M | $-444M | $-441M | $681M | $-97M | $-154M | $-81M | $-54M | |
| EPS (Basic) | $-9.73 | $-8.68 | $-1.45 | $-1.97 | $-2.86 | $-2.49 | $-2.52 | $4.02 | $-0.62 | $-1.10 | · | · | |
| EPS (Diluted) | $-9.73 | $-8.68 | $-1.45 | $-1.97 | $-2.86 | $-2.49 | $-2.52 | $3.78 | $-0.62 | $-1.10 | · | · | |
| Shares (Basic) | 16,870,930 | 13,710,775 | 190,001,000 | 187,138,000 | 183,298,000 | 178,581,000 | 174,993,000 | 169,600,000 | 155,953,000 | 139,596,000 | · | · | |
| Shares (Diluted) | 16,870,930 | 13,710,775 | 190,001,000 | 187,138,000 | 183,298,000 | 178,581,000 | 174,993,000 | 180,119,000 | 155,953,000 | 139,596,000 | · | · | |
| EBITDA | $-140M | $-101M | $-257M | $-364M | $-433M | $-413M | $-429M | $697M | $-47M | $-113M | $-29M | · |
Neraca 24
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $44M | $35M | $88M | $25M | $199M | $96M | $195M | $5M | $60M | $56M | $12M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $291M | $329M | $253M | $225M | |
| Receivables | · | $0 | $1M | $6M | $22M | $39M | $37M | $43M | $5M | $16M | $20M | $4M | |
| Inventory | $0 | $0 | $16M | $19M | $16M | $15M | $13M | $11M | $11M | $11M | $11M | $13M | |
| Other Current Assets | $21M | $6M | $10M | $16M | $23M | $22M | $15M | $21M | $8M | $10M | $10M | $9M | |
| Current Assets | $266M | $261M | $331M | $546M | $796M | $1.14B | $1.42B | $1.44B | $327M | $426M | $350M | $288M | |
| PP&E (Net) | $2M | $3M | $19M | $32M | $61M | $60M | $66M | $49M | $47M | $66M | $71M | $70M | |
| Accum. Depreciation | · | $16M | $87M | $125M | $148M | $138M | $128M | $121M | $115M | $111M | $103M | $94M | |
| Goodwill | · | · | $0 | $77M | $77M | $77M | $77M | $77M | $77M | $77M | $77M | $77M | |
| Other Non-current Assets | $14M | $5M | $5M | $2M | $3M | $1M | $344.0K | $4M | $994.0K | $817.0K | $754.0K | $7M | |
| Total Assets | $280M | $304M | $398M | $711M | $1.12B | $1.54B | $1.98B | $2.15B | $509M | $569M | $499M | $442M | |
| Accounts Payable | $11M | $12M | $10M | $13M | $10M | $22M | $19M | $6M | $5M | $3M | $2M | $3M | |
| Accrued Liabilities | $22M | $30M | $22M | $37M | · | · | · | · | · | · | · | $6M | |
| Current Liabilities | $54M | $61M | $51M | $68M | $85M | $116M | $354M | $82M | $56M | $72M | $61M | $64M | |
| Capital Leases | $65M | $83M | $99M | $113M | $126M | $136M | $143M | $0 | · | $2M | $1M | $4M | |
| Other Non-current Liabilities | $9M | $7M | $5M | $8M | $4M | $9M | $768.0K | $10M | $6M | $7M | $10M | $15M | |
| Total Liabilities | $191M | $243M | $267M | $344M | $438M | $461M | $572M | $433M | $421M | $481M | $492M | $405M | |
| Common Stock | $2.0K | $1.0K | $19.0K | $19.0K | $19.0K | $18.0K | $17.0K | $17.0K | $15.0K | $15.0K | $13.0K | $13.0K | |
| Retained Earnings | $-3.76B | $-3.60B | $-3.48B | $-3.20B | $-2.83B | $-2.31B | $-1.86B | $-1.42B | $-2.12B | $-2.02B | $-1.87B | $-1.79B | |
| Treasury Stock | · | $3M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $17.0K | $61.0K | $80.0K | $-7M | $-4M | $-2M | $-1M | $-6M | $-2M | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $90M | $61M | $131M | $367M | $680M | $1.08B | $1.41B | $1.72B | $88M | $88M | $6M | $36M | |
| Liabilities + Equity | $280M | $304M | $398M | $711M | $1.12B | $1.54B | $1.98B | $2.15B | $509M | $569M | $499M | $442M | |
| Shares Outstanding | 20,378,832 | 12,385,001 | 12,757,984 | 188,560,000 | 185,468,000 | 180,091,000 | 176,505,000 | 173,530,000 | 159,524,000 | 153,212,000 | 135,289,000 | 131,216,000 |
Arus Kas 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $4M | $7M | $12M | $13M | $12M | $11M | $9M | $13M | $13M | $11M | $13M | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $17M | |
| Deferred Tax | $64.0K | $-10.0K | $-140.0K | $3M | $-102.0K | $-36.0K | $-21.0K | $93.0K | $35.0K | $-115.0K | $-22.0K | $-31.0K | |
| Other Non-cash | · | $-61M | $77M | $49M | $98M | $119M | $101M | $28M | $4M | · | · | · | |
| Operating Cash Flow | $-209M | $-176M | $-193M | $-304M | $-413M | $-313M | $-329M | $718M | $-80M | $-117M | $-73M | $-142M | |
| CapEx | $171.0K | $1M | $865.0K | $6M | $15M | $7M | $26M | $14M | $10M | $6M | $11M | $10M | |
| Investing Cash Flow | $-1M | $143M | $140M | $366M | $203M | $496M | $207M | $-1.38B | $-29M | $-82M | · | · | |
| Stock Repurchased | $0 | $3M | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-3M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $181M | $42M | $30.0K | $2M | $36M | $-80M | $23M | $852M | $54M | $204M | · | · | |
| Net Change in Cash | $-29M | $9M | $-53M | $63M | $-174M | $103M | $-99M | $190M | $-55M | $4M | $43M | $-27M | |
| Taxes Paid | $-195.0K | $76.0K | $3M | $272.0K | $325.0K | $539.0K | $555.0K | $618.0K | $556.0K | $757.0K | $860.0K | $964.0K | |
| Free Cash Flow | $-209M | $-177M | $-193M | $-310M | $-428M | $-321M | $-355M | $704M | $-90M | $-123M | $-84M | · | |
| Levered FCF | · | · | · | $-310M | $-428M | $-327M | $-376M | $682M | $-112M | $-146M | $-103M | · |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -253.7% | -106.9% | -292.6% | -408.6% | -437.8% | -278.0% | -383.9% | 57.6% | -19.4% | -68.2% | -12.7% | · | |
| Net Margin | -297.1% | -120.9% | -306.3% | -400.0% | -514.0% | -290.6% | -384.5% | 57.1% | -31.4% | -92.8% | -35.2% | · | |
| Pretax Margin | -297.3% | -121.1% | -306.5% | -396.5% | -513.5% | -290.3% | -383.9% | 57.2% | -31.2% | -92.3% | -35.0% | · | |
| EBITDA Margin | -253.7% | -102.7% | -284.8% | -395.4% | -425.0% | -269.8% | -374.3% | 58.4% | -15.3% | -68.2% | -12.7% | · | |
| ROA | -56.2% | -33.9% | -49.8% | -40.3% | -39.5% | -25.3% | -21.3% | 51.2% | -17.9% | -28.8% | -17.2% | · | |
| ROE | -500.1% | -217.0% | -190.2% | -94.5% | -70.7% | -39.5% | -30.4% | 38.9% | -109.9% | -324.7% | -379.7% | · | |
| ROIC | -155.8% | -172.9% | -201.2% | -103.5% | -65.7% | -39.5% | -31.4% | 40.0% | -68.3% | -128.8% | -459.7% | · |
Likuiditas & Solvabilitas 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.3 | 6.5 | 8.0 | 9.3 | 9.8 | 4.0 | 17.5 | 5.8 | 5.9 | 5.7 | · | |
| Quick Ratio | 0.3 | 0.7 | 0.7 | 1.4 | 0.6 | 2.1 | 0.4 | 2.9 | 5.4 | 5.6 | 5.4 | · | |
| Interest Coverage | · | · | · | · | · | -62.1 | -20.6 | 31.9 | -2.7 | -5.0 | -1.6 | · |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.9 | 0.6 | 0.3 | 0.5 | · | |
| Inventory Turnover | · | 3.8 | 1.9 | 1.2 | 1.6 | 1.4 | 1.8 | 2.2 | 2.8 | 2.7 | 2.8 | · | |
| Receivables Turnover | · | 163.4 | 25.1 | 6.5 | 3.3 | 4.0 | 2.9 | 49.5 | 29.7 | 9.3 | 19.6 | · |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -43.9% | 9.2% | -2.1% | -9.7% | -33.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -15.7% | -1.1% | -16.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -18.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $55M | $98M | $90M | $92M | $102M | $153M | $115M | $1.19B | $308M | $165M | $231M | $201M | |
| Net Income TTM | $-164M | $-119M | $-276M | $-368M | $-524M | $-444M | $-441M | $681M | $-97M | $-154M | $-81M | $-54M | |
| Market Cap | $862M | $2.59B | $1.61B | $6.39B | $37.59B | $45.92B | $57.16B | $85.56B | $142.90B | $28.20B | $34.19B | · | |
| P/E | -4.3 | -1.6 | -5.8 | -17.2 | -70.9 | -102.4 | -128.5 | 130.4 | -1444.8 | -167.3 | -414.3 | -516.7 | |
| P/S | 15.6 | 26.3 | 17.8 | 69.4 | 368.8 | 300.3 | 498.7 | 71.7 | 464.4 | 170.5 | 148.2 | · | |
| P/B | 9.6 | 42.7 | 12.3 | 17.4 | 55.3 | 42.6 | 40.7 | 49.8 | 1627.1 | 320.0 | 5318.8 | · | |
| P / Tangible Book | 9.6 | 42.7 | 12.3 | 22.0 | 62.3 | 45.9 | · | · | · | · | · | · | |
| P / Cash Flow | -4.1 | -14.7 | -8.3 | -21.0 | -91.1 | -146.6 | -173.9 | 119.1 | -1777.1 | -241.0 | -467.9 | · | |
| P / FCF | -4.1 | -14.6 | -8.3 | -20.6 | -87.9 | -143.3 | -161.0 | 121.5 | -1586.2 | -228.5 | -405.7 | · | |
| Earnings Yield | -23.0% | -62.2% | -17.3% | -5.8% | -1.4% | -0.98% | -0.78% | 0.77% | -0.07% | -0.60% | -0.24% | -0.19% |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $11M | $22M | $12M | $11M | $10M | $29M | $24M | $23M | $22M | $24M | $24M | $20M | $22M | $22M | $24M | |
| Cost of Revenue | · | · | $0 | $0 | $0 | $0 | $8M | $4M | $10M | $9M | $7M | $12M | $7M | $7M | $6M | $5M | |
| R&D Expense | $39M | $36M | $30M | $27M | $30M | $30M | $29M | $35M | $30M | $27M | $30M | $24M | $30M | $30M | $35M | $34M | |
| SG&A Expense | $13M | $13M | $11M | $16M | $17M | $24M | $17M | $19M | $21M | $20M | $17M | $21M | $18M | $21M | $22M | $23M | |
| Operating Expenses | $52M | $50M | $49M | $43M | $47M | $55M | $15M | $58M | $73M | $57M | $57M | $69M | $71M | $156M | $74M | $78M | |
| Operating Income | $-42M | $-39M | $-28M | $-32M | $-36M | $-45M | $14M | $-34M | $-50M | $-35M | $-34M | $-45M | $-51M | $-135M | $-52M | $-54M | |
| Interest Income | $9M | $4M | $3M | $3M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $5M | $4M | · | · | |
| Other Non-op | $-100.0K | $-336.0K | $-44.0K | $-121.0K | $260.0K | $266.0K | $-135.0K | $-120.0K | $-36.0K | $-99.0K | $-6M | $-335.0K | $736.0K | $-301.0K | $-4M | $2M | |
| Pretax Income | $-40M | $-43M | $-43M | $-35M | $-39M | $-46M | $7M | $-37M | $-52M | $-37M | $-42M | $-46M | $-51M | $-137M | $-57M | $-59M | |
| Income Tax | $2.0K | $64.0K | $31.0K | $-33.0K | $-188.0K | $52.0K | $-259.0K | $9.0K | $46.0K | $-35.0K | $-29.0K | $-61.0K | $-47.0K | $-63.0K | $3M | $-155.0K | |
| Net Income | $-41M | $-45M | $-36M | $-36M | $-42M | $-51M | $7M | $-37M | $-52M | $-37M | $-42M | $-46M | $-51M | $-137M | $-60M | $-59M | |
| EPS (Basic) | $-1.23 | $-1.82 | $-4.67 | $-1.87 | $-2.95 | $-3.62 | $-2.07 | $-2.66 | $-3.76 | $-0.19 | $-0.21 | $-0.24 | $-0.27 | $-0.73 | $-0.32 | $-0.31 | |
| EPS (Diluted) | $-1.23 | $-1.82 | $-4.67 | $-1.87 | $-2.95 | $-3.62 | $-2.07 | $-2.66 | $-3.76 | $-0.19 | $-0.21 | $-0.24 | $-0.27 | $-0.73 | $-0.32 | $-0.31 | |
| Shares (Basic) | 33,054,865 | 24,736,066 | -227,086,936 | 18,946,559 | 14,087,307 | 14,063,402 | -208,906,454 | 13,949,851 | 13,921,378 | 194,746,000 | -378,936,000 | 190,406,000 | 189,656,000 | 188,875,000 | -373,151,000 | 187,641,000 | |
| Shares (Diluted) | 33,054,865 | 24,736,066 | -227,086,936 | 18,946,559 | 14,087,307 | 14,063,402 | -208,906,454 | 13,949,851 | 13,921,378 | 194,746,000 | -378,936,000 | 190,406,000 | 189,656,000 | 188,875,000 | -373,151,000 | 187,641,000 | |
| EBITDA | $-42M | $-39M | · | $-32M | $-36M | $-45M | · | $-34M | $-50M | $-35M | · | $-45M | $-51M | $-135M | · | $-54M |
Neraca 23
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $150M | $15M | $41M | $43M | $39M | $44M | $30M | $28M | $49M | $35M | $65M | $51M | $77M | $88M | $106M | |
| Receivables | · | · | · | · | · | · | · | $0 | $1M | $4M | $1M | $2M | $1M | $3M | $6M | $12M | |
| Inventory | · | · | $0 | · | · | · | $0 | $0 | $14M | $16M | $16M | $15M | $21M | $20M | $19M | $19M | |
| Other Current Assets | $55M | $20M | $21M | $11M | $11M | $11M | $6M | $9M | $8M | $11M | $10M | $9M | $10M | $11M | $16M | $23M | |
| Current Assets | $739M | $589M | $266M | $281M | $187M | $230M | $261M | $286M | $295M | $320M | $331M | $399M | $441M | $491M | $546M | $599M | |
| PP&E (Net) | · | · | $2M | $3M | $3M | $3M | $3M | $4M | $15M | $17M | $19M | $20M | $23M | $27M | $32M | $37M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $16M | $88M | · | $87M | $88M | $108M | $111M | $125M | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $77M | $77M | |
| Other Non-current Assets | $17M | $11M | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $2M | $1M | $2M | $2M | |
| Total Assets | $1.10B | $763M | $280M | $301M | $208M | $256M | $304M | $308M | $343M | $396M | $398M | $442M | $494M | $562M | $711M | $781M | |
| Accounts Payable | $25M | $10M | $11M | $16M | $14M | $18M | $12M | $9M | $6M | $9M | $10M | $3M | $3M | $4M | $13M | $5M | |
| Accrued Liabilities | $23M | $25M | $22M | $29M | $35M | $31M | $30M | $32M | $30M | $24M | $22M | $30M | $29M | $37M | $37M | · | |
| Current Liabilities | $71M | $58M | $54M | $66M | $71M | $71M | $61M | $68M | $57M | $52M | $51M | $52M | $51M | $60M | $68M | $84M | |
| Capital Leases | $56M | $61M | $65M | $70M | $74M | $78M | $83M | $87M | $91M | $95M | $99M | $102M | $106M | $109M | $113M | $116M | |
| Other Non-current Liabilities | $8M | $8M | $9M | $5M | $6M | $7M | $7M | $7M | $8M | $4M | $5M | $5M | $5M | $6M | $8M | $3M | |
| Total Liabilities | $192M | $187M | $191M | $216M | $232M | $243M | $243M | $259M | $264M | $269M | $267M | $283M | $297M | $321M | $344M | $369M | |
| Common Stock | $3.0K | $3.0K | $2.0K | $2.0K | $1.0K | $19.0K | $1.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | $19.0K | |
| Retained Earnings | $-3.85B | $-3.81B | $-3.76B | $-3.72B | $-3.69B | $-3.65B | $-3.60B | $-3.60B | $-3.57B | $-3.51B | $-3.48B | $-3.44B | $-3.39B | $-3.34B | $-3.20B | $-3.14B | |
| Treasury Stock | · | · | · | $0 | $3M | $3M | $3M | $3M | $3M | $3M | · | · | · | · | · | · | |
| AOCI | $-2M | $-1M | $17.0K | $56.0K | $-14.0K | $39.0K | $61.0K | $355.0K | $-494.0K | $-403.0K | $80.0K | $-6M | $-6M | $-6M | $-7M | $-8M | |
| Stockholders' Equity | $903M | $576M | $90M | $85M | $-24M | $14M | $61M | $49M | $80M | $127M | $131M | $159M | $197M | $241M | $367M | $412M | |
| Liabilities + Equity | $1.10B | $763M | $280M | $301M | $208M | $256M | $304M | $308M | $343M | $396M | $398M | $442M | $494M | $562M | $711M | $781M | |
| Shares Outstanding | 20,378,832 | 20,378,832 | 20,378,832 | 19,652,513 | 12,457,252 | 186,103,000 | 12,385,001 | 184,458,000 | 184,061,000 | 183,624,000 | 191,384,000 | 190,771,000 | 190,119,000 | 189,235,000 | 188,560,000 | 187,954,000 |
Arus Kas 12
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $156.0K | $151.0K | $190.0K | $196.0K | $214.0K | $426.0K | $332.0K | $993.0K | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $2.0K | $-31.0K | $57.0K | $-38.0K | $2M | $-15.0K | $-27.0K | $-2M | $3M | $0 | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $17M | |
| Operating Cash Flow | $-76M | $-44M | $-65M | $-49M | $-46M | $-49M | $-46M | $-44M | $-38M | $-48M | $-47M | $-42M | $-52M | $-52M | $-58M | $-83M | |
| CapEx | $94.0K | $18.0K | $18.0K | $114.0K | $37.0K | $2.0K | $459.0K | $666.0K | $186.0K | $157.0K | $237.0K | $33.0K | $162.0K | $433.0K | $512.0K | $181.0K | |
| Investing Cash Flow | $-399M | $-351M | $372.0K | $-95M | $50M | $44M | $60M | $46M | $17M | $19M | $17M | $56M | $25M | $41M | $40M | $111M | |
| Stock Repurchased | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3M | $0 | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-3M | · | · | · | · | · | · | |
| Financing Cash Flow | $365M | $530M | $39M | $142M | $211.0K | $7.0K | $83.0K | $13.0K | $19.0K | $42M | $12.0K | $0 | $18.0K | $0 | $103.0K | $0 | |
| Net Change in Cash | $-110M | $134M | $-26M | $-2M | $4M | $-5M | $14M | $2M | $-21M | $13M | $-30M | $14M | $-26M | $-11M | $-18M | $28M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $272.0K | $-85.0K | |
| Free Cash Flow | · | $-44M | · | · | · | $-49M | · | · | · | $-48M | · | · | · | $-52M | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -417.9% | -359.6% | · | -268.6% | -324.2% | -425.8% | · | -142.4% | -211.9% | -163.7% | · | -185.8% | -246.8% | -623.8% | · | -229.9% | |
| Net Margin | -401.0% | -413.4% | · | -301.3% | -372.2% | -486.4% | · | -153.6% | -222.9% | -170.1% | · | -189.8% | -249.4% | -634.5% | · | -249.9% | |
| Pretax Margin | -397.8% | -396.7% | · | -297.0% | -352.5% | -443.3% | · | -153.6% | -222.7% | -170.2% | · | -190.1% | -249.6% | -634.8% | · | -250.6% | |
| EBITDA Margin | -417.9% | -359.6% | · | -268.6% | -324.2% | -425.8% | · | -142.4% | -211.9% | -163.7% | · | -185.8% | -246.8% | -623.8% | · | -229.9% | |
| ROA | -6.2% | -8.8% | · | -11.7% | -15.1% | -15.6% | · | -9.9% | -12.5% | -7.7% | · | -7.5% | -7.5% | -17.3% | · | -5.7% | |
| ROE | -9.2% | -15.2% | · | -53.0% | -150.0% | -72.5% | · | -35.6% | -37.9% | -20.0% | · | -16.0% | -15.6% | -32.3% | · | -9.7% | |
| ROIC | -4.7% | -6.8% | · | -37.2% | 148.9% | -324.5% | · | -70.3% | -62.5% | -27.9% | · | -28.1% | -25.7% | -55.9% | · | -13.1% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.4 | 10.2 | · | 4.2 | 2.6 | 3.2 | · | 4.2 | 5.1 | 6.1 | · | 7.7 | 8.7 | 8.2 | · | 7.1 | |
| Quick Ratio | 0.6 | 2.6 | · | 0.6 | 0.6 | 0.5 | · | 0.4 | 0.5 | 1.0 | · | 1.3 | 1.0 | 1.3 | · | 1.4 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.6 | 0.6 | 0.5 | · | 0.7 | 0.4 | 0.4 | · | 0.3 | |
| Receivables Turnover | · | · | · | · | · | · | · | 21.9 | 18.6 | 6.5 | · | 3.5 | 3.6 | 1.3 | · | 1.2 |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44M | $44M | · | $58M | $69M | $80M | · | $93M | $90M | $88M | · | $90M | $87M | $92M | · | $95M | |
| Net Income TTM | $-163M | $-173M | · | $-165M | $-182M | $-177M | · | $-172M | $-186M | $-271M | · | $-293M | $-406M | $-446M | · | $-454M | |
| Market Cap | $1.42B | $1.47B | · | $1.12B | $322M | $1.90B | · | $3.60B | $3.42B | $2.56B | · | $1.72B | $1.65B | $1.99B | · | $9.02B | |
| P/E | -8.9 | -7.0 | · | -7.4 | -2.7 | -1.5 | · | -2.8 | -4.2 | -9.8 | · | -5.8 | -4.0 | -4.4 | · | -0.1 | |
| P/S | 32.4 | 33.1 | · | 19.4 | 4.6 | 23.8 | · | 38.5 | 38.1 | 29.1 | · | 19.1 | 18.9 | 21.7 | · | 94.9 | |
| P/B | 1.6 | 2.5 | · | 13.1 | -13.3 | 138.2 | · | 73.6 | 43.0 | 20.2 | · | 10.8 | 8.4 | 8.2 | · | 21.9 | |
| P / Tangible Book | 1.6 | 2.5 | · | 13.1 | · | 138.2 | · | 73.6 | 43.0 | 20.2 | · | 10.8 | 8.4 | 8.2 | · | 26.9 | |
| P / Cash Flow | · | -33.1 | · | · | · | -38.7 | · | · | · | -53.5 | · | · | · | -38.3 | · | · | |
| P / FCF | · | -33.1 | · | · | · | -38.7 | · | · | · | -53.3 | · | · | · | -38.0 | · | · | |
| Earnings Yield | -11.3% | -14.3% | · | -13.6% | -37.2% | -67.2% | · | -35.1% | -24.0% | -10.2% | · | -17.2% | -24.8% | -22.7% | · | -1649.3% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $55M | $98M | $90M | $92M | $102M |
| Margin Operasi % | -253.7% | -106.9% | -292.6% | -408.6% | -437.8% |
| Laba Bersih | $-164M | $-119M | $-276M | $-368M | $-524M |
| EPS Dilusian | $-9.73 | $-8.68 | $-1.45 | $-1.97 | $-2.86 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 5.0 | 4.3 | 6.5 | 8.0 | 9.3 |
| Rasio Cepat | 0.3 | 0.7 | 0.7 | 1.4 | 0.6 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-209M | $-177M | $-193M | $-310M | $-428M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 269 pengaju · $2.1B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 88 (+20 vs Kuartal sebelumnya) | 41 (+9 vs Kuartal sebelumnya) | 91 (+21 vs Kuartal sebelumnya) | 48 (-8 vs Kuartal sebelumnya) | +8.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Two Seas Capital LP | $215.868.856 | 3.092.234 | 10,35% | Saham |
| FMR LLC | $192.088.149 | 2.751.585 | 9,21% | Saham |
| BVF INC/IL | $166.920.946 | 2.391.075 | 8,00% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $104.495.029 | 1.496.849 | 5,01% | Saham |
| TWO SIGMA INVESTMENTS, LP | $83.911.899 | 1.202.004 | 4,02% | Saham |
| Vestal Point Capital, LP | $69.810.000 | 1.000.000 | 3,35% | Saham |
| STATE STREET CORP | $63.504.691 | 909.679 | 3,04% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $57.502.497 | 823.700 | 2,76% | Opsi beli |
| Prosight Management, LP | $56.546.100 | 810.000 | 2,71% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $52.759.799 | 755.586 | 2,53% | Saham |
| ARMISTICE CAPITAL, LLC | $50.542.440 | 724.000 | 2,42% | Saham |
| GILDER GAGNON HOWE & CO LLC | $41.946.944 | 600.873 | 2,01% | Saham |
| MILLENNIUM MANAGEMENT LLC | $33.377.557 | 478.120 | 1,60% | Saham |
| BRAIDWELL LP | $33.063.203 | 473.617 | 1,59% | Saham |
| Sofinnova Investments, Inc. | $32.933.775 | 471.763 | 1,58% | Saham |
| Woodline Partners LP | $32.871.784 | 470.875 | 1,58% | Saham |
| ORBIMED ADVISORS LLC | $32.485.804 | 465.346 | 1,56% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $27.540.045 | 394.500 | 1,32% | Opsi jual |
| EMERALD ADVISERS, LLC | $27.236.930 | 390.158 | 1,31% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $24.331.577 | 348.540 | 1,17% | Saham |
| DAFNA Capital Management LLC | $22.226.108 | 318.380 | 1,07% | Saham |
| Deep Track Capital, LP | $20.943.000 | 300.000 | 1,00% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19.893.826 | 284.971 | 0,95% | Saham |
| 22NW, LP | $19.624.638 | 281.115 | 0,94% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.475.384 | 278.977 | 0,93% | Saham |
| PRIMECAP MANAGEMENT CO/CA/ | $19.047.658 | 272.850 | 0,91% | Saham |
| Nearwater Capital Markets, Ltd | $18.255.315 | 261.500 | 0,88% | Saham |
| BARCLAYS PLC | $17.968.815 | 257.396 | 0,86% | Saham |
| EMERALD MUTUAL FUND ADVISERS TRUST | $17.842.528 | 255.587 | 0,86% | Saham |
| ADAR1 Capital Management, LLC | $17.046.485 | 244.184 | 0,82% | Saham |
| Creek Drive Management Group LLC | $16.963.830 | 243.000 | 0,81% | Saham |
| SEVEN GRAND MANAGERS, LLC | $16.754.400 | 240.000 | 0,80% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $16.724.731 | 239.575 | 0,80% | Saham |
| NORGES BANK | $15.030.093 | 215.300 | 0,72% | Saham |
| Bronte Capital Management Pty Ltd. | $13.852.678 | 198.434 | 0,66% | Saham |
| TWO SIGMA ADVISERS, LP | $13.039.744 | 308.414 | 0,63% | Saham |
| CITADEL ADVISORS LLC | $12.251.655 | 175.500 | 0,59% | Opsi jual |
| GREAT POINT PARTNERS LLC | $12.216.750 | 175.000 | 0,59% | Saham |
| Caption Management, LLC | $11.944.491 | 171.100 | 0,57% | Opsi beli |
| MILLENNIUM MANAGEMENT LLC | $11.867.700 | 170.000 | 0,57% | Opsi beli |
| CITADEL ADVISORS LLC | $11.434.878 | 163.800 | 0,55% | Opsi beli |
| AMERIPRISE FINANCIAL INC | $11.050.085 | 158.288 | 0,53% | Saham |
| Quinn Opportunity Partners LLC | $10.686.236 | 153.076 | 0,51% | Saham |
| GOLDMAN SACHS GROUP INC | $10.011.801 | 143.415 | 0,48% | Saham |
| Rhenman & Partners Asset Management AB | $9.860.662 | 141.250 | 0,47% | Saham |
| Qube Research & Technologies Ltd | $9.111.671 | 130.521 | 0,44% | Saham |
| LMR Partners LLP | $9.075.300 | 130.000 | 0,44% | Opsi jual |
| Soleus Capital Management, L.P. | $8.960.951 | 128.362 | 0,43% | Saham |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $8.570.364 | 122.767 | 0,41% | Saham |
| Stonepine Capital Management, LLC | $8.422.856 | 120.654 | 0,40% | Saham |
| SummitTX Capital, L.P. | $7.883.923 | 112.934 | 0,38% | Saham |
| APEIRON CAPITAL Ltd | $7.429.948 | 106.431 | 0,36% | Saham |
| CITIGROUP INC | $7.034.824 | 100.771 | 0,34% | Saham |
| ING GROEP NV | $6.981.000 | 100.000 | 0,33% | Saham |
| LMR Partners LLP | $6.981.000 | 100.000 | 0,33% | Saham |
| Susquehanna Portfolio Strategies, LLC | $6.685.704 | 95.770 | 0,32% | Saham |
| Militia Capital Management LLC | $6.282.900 | 90.000 | 0,30% | Saham |
| ACT CAPITAL MANAGEMENT, LLC | $6.234.033 | 89.300 | 0,30% | Saham |
| Tetragon Partners GP Ltd | $6.073.191 | 86.996 | 0,29% | Saham |
| READYSTATE ASSET MANAGEMENT LP | $5.941.529 | 85.110 | 0,28% | Saham |
| Birchview Capital, LP | $5.654.610 | 81.000 | 0,27% | Saham |
| BlackRock, Inc. | $5.444.412 | 77.989 | 0,26% | Saham |
| GROUP ONE TRADING LLC | $4.912.600 | 70.371 | 0,24% | Saham |
| ALGERT GLOBAL LLC | $4.686.345 | 67.130 | 0,22% | Saham |
| Moody Aldrich Partners LLC | $4.477.264 | 64.135 | 0,21% | Saham |
| WOLVERINE TRADING, LLC | $4.330.620 | 73.500 | 0,21% | Opsi jual |
| Swiss National Bank | $4.300.296 | 61.600 | 0,21% | Saham |
| F/m Investments LLC | $4.229.439 | 60.585 | 0,20% | Saham |
| BANK OF AMERICA CORP /DE/ | $4.227.764 | 60.561 | 0,20% | Saham |
| ExodusPoint Capital Management, LP | $4.084.374 | 58.507 | 0,20% | Saham |
| Trexquant Investment LP | $3.956.831 | 56.680 | 0,19% | Saham |
| K2 PRINCIPAL FUND, L.P. | $3.522.962 | 50.465 | 0,17% | Saham |
| WOLVERINE TRADING, LLC | $3.403.101 | 57.758 | 0,16% | Saham |
| RHUMBLINE ADVISERS | $3.008.381 | 43.094 | 0,14% | Saham |
| MORGAN STANLEY | $2.943.050 | 42.158 | 0,14% | Saham |
| Voleon Capital Management LP | $2.850.901 | 40.838 | 0,14% | Saham |
| Anson Funds Management LP | $2.829.748 | 40.535 | 0,14% | Saham |
| Atom Investors LP | $2.828.631 | 40.519 | 0,14% | Saham |
| WOLVERINE TRADING, LLC | $2.792.808 | 47.400 | 0,13% | Opsi beli |
| Burkehill Global Management, LP | $2.792.400 | 40.000 | 0,13% | Saham |
| NOMURA HOLDINGS INC | $2.792.400 | 40.000 | 0,13% | Opsi jual |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $2.708.768 | 38.802 | 0,13% | Saham |
| NOMURA HOLDINGS INC | $2.698.645 | 38.657 | 0,13% | Saham |
| Jefferies Financial Group Inc. | $2.664.299 | 38.165 | 0,13% | Saham |
| ALLIANCEBERNSTEIN L.P. | $2.590.200 | 36.000 | 0,12% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $2.575.780 | 36.897 | 0,12% | Saham |
| ALPS ADVISORS INC | $2.386.664 | 34.188 | 0,11% | Saham |
| FRED ALGER MANAGEMENT, LLC | $2.350.712 | 33.673 | 0,11% | Saham |
| TUDOR INVESTMENT CORP ET AL | $2.345.616 | 33.600 | 0,11% | Opsi beli |
| Bank of New York Mellon Corp | $2.306.522 | 33.040 | 0,11% | Saham |
| Ghisallo Capital Management LLC | $2.233.920 | 32.000 | 0,11% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.063.670 | 28.682 | 0,10% | Saham |
| Blackstone Inc. | $2.002.011 | 28.678 | 0,10% | Saham |
| KVP Capital Advisors, LP | $1.877.889 | 26.900 | 0,09% | Saham |
| Ishara Investments LP | $1.860.437 | 26.650 | 0,09% | Saham |
| Erste Asset Management GmbH | $1.830.920 | 28.000 | 0,09% | Saham |
| Caption Management, LLC | $1.822.041 | 26.100 | 0,09% | Opsi jual |
| WINTON GROUP Ltd | $1.808.079 | 25.900 | 0,09% | Saham |
| K2 PRINCIPAL FUND, L.P. | $1.745.250 | 25.000 | 0,08% | Opsi beli |
| Empowered Funds, LLC | $1.636.416 | 23.441 | 0,08% | Saham |
Orang dalam perusahaan 40 orang dalam · 20 pejabat · 18 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Howard W Robin | President & CEO | 24 Juli 2026 A | 55.045 | 0 | 20 | $-2.224.055 |
| Jillian B. Thomsen | Chief Financial Officer | 16 Feb. 2023 S | 313.497 | 0 | 0 | $0 |
| Gil M Labrucherie | SVP, COO & CFO | 16 Mei 2022 S | 312.905 | 0 | 0 | $0 |
| Timothy Harkness | SVP & Chief Financial Officer | 23 Agu 2007 A | — | 0 | 0 | $0 |
| Louis Drapeau | Sr. VP Finance, CFO | 14 Mei 2007 A | 6.000 | 0 | 0 | $0 |
| Milton J Harris | President of Nektar AL | 4 Maret 2004 S | 743.904 | 0 | 0 | $0 |
| John Nicholson | SVP & Chief Operating Officer | 16 Agu 2019 S | 162.759 | 0 | 0 | $0 |
| Bharat M Chowrira | Chief Operating Officer | 1 Feb. 2010 A | — | 0 | 0 | $0 |
| Jonathan Zalevsky | Chief R&D Officer | 24 Juli 2026 A | 9.756 | 0 | 12 | $-1.052.364 |
| Mark Andrew Wilson | Chief Legal Officer | 21 Nov. 2025 A | 21.585 | 0 | 2 | $-52.171 |
| John Northcott | SVP & Chief Commercial Officer | 16 Mei 2022 S | 223.210 | 0 | 0 | $0 |
| Stephen K Doberstein | SVP & Chief Scientific Officer | 5 Sep. 2019 P | 107.668 | 0 | 0 | $0 |
| Maninder Hora | SVP Pharma Dev & Mfg Ops | 16 Mei 2019 S | 94.694 | 0 | 0 | $0 |
| Ivan P. Gergel | SVP & Chief Medical Officer | 15 Nov. 2017 A | 56.553 | 0 | 0 | $0 |
| Robert Medve | SVP & Chief Medical Officer | 5 Feb. 2014 A | — | 0 | 0 | $0 |
| Rinko Ghosh | Chief Business Officer | 6 Feb. 2013 A | 9.753 | 0 | 0 | $0 |
| Randall W Moreadith | SVP Drug Development | 23 Feb. 2009 A | — | 0 | 0 | $0 |
| John Stuart Patton | Chief Scientific Officer | 14 Nov. 2008 M | 313.880 | 0 | 0 | $0 |
| Nevan C Elam | SVP & Head of Pulmonary Bus | 25 Feb. 2008 A | 1.400 | 0 | 0 | $0 |
| David Johnston | SVP, Research & Development | 14 Mei 2007 D | 6.600 | 0 | 0 | $0 |
| Diana Brainard | Direktur | 30 Sep. 2025 A | 28.560 | 0 | 0 | $0 |
| Jeffrey Robert Ajer | Direktur | 30 Sep. 2025 A | 34.153 | 0 | 0 | $0 |
| Robert Chess | Direktur | 30 Sep. 2025 A | 255.273 | 0 | 0 | $0 |
| Scott R Greer | Direktur | 30 Sep. 2025 A | 303.574 | 0 | 0 | $0 |
| Roy A Whitfield | Direktur | 30 Sep. 2025 A | 216.250 | 0 | 0 | $0 |
| Myriam Curet | Direktur | 19 Sep. 2023 A | 27.418 | 0 | 0 | $0 |
| Karin Eastham | Direktur | 16 Sep. 2022 A | 23.233 | 0 | 0 | $0 |
| Lutz Lingnau | Direktur | 22 Sep. 2020 A | 35.800 | 0 | 0 | $0 |
| Christopher A Kuebler | Direktur | 27 Sep. 2018 A | 45.250 | 0 | 0 | $0 |
| Dennis L Winger | Direktur | 21 Agu 2018 M | 42.750 | 0 | 0 | $0 |
| Joseph J Krivulka | Direktur | 19 Sep. 2017 A | 82.000 | 0 | 0 | $0 |
| Susan Wang | Direktur | 20 Nov. 2015 M | 20.000 | 0 | 0 | $0 |
| BROWN MICHAEL A/CA | Direktur | 15 Sep. 2009 A | 10.000 | 0 | 0 | $0 |
| Hoyoung Huh | Direktur | 2 Des. 2008 A | — | 0 | 0 | $0 |
| Irwin Lerner | Direktur | 2 Des. 2008 A | 10.000 | 0 | 0 | $0 |
| James B Glavin | Direktur | 4 Sep. 2003 A | — | 0 | 0 | $0 |
| Masuoka K. Lorianne | — | 8 Feb. 2011 A | — | 0 | 0 | $0 |
| Ajit Gill | President & CEO | 23 Maret 2006 S | 87.991 | 0 | 0 | $0 |
| Ajay Bansal | — | 10 Maret 2006 S | 5.166 | 0 | 0 | $0 |
| Melvin Perelman | — | 2 Sep. 2004 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Nektar Therapeutics ( | 22 Agu 2005 | — | Pengajuan awal | M&A / penjualan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 28 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 3,14% | 50.876 NS | 31 Mei 2026 | N-PORT |
| SPIT · RBB Fund, Inc. | 3,11% | 10.455 NS | 30 April 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,55% | 2.353 NS | 30 April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 1,15% | 5.045 NS | 30 April 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,58% | 1.726 SH | 8 Agu 2026 | Harian |
| IHE · iShares Trust | 0,55% | 120.730 SH | 8 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,16% | 59.612 SH | 8 Agu 2026 | Harian |
| IWO · iShares Trust | 0,14% | 278.376 SH | 8 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 33.135 SH | 8 Agu 2026 | Harian |
| TMFX · RBB Fund, Inc. | 0,09% | 455 NS | 31 Mei 2026 | N-PORT |
| IWM · iShares Trust | 0,08% | 877.973 SH | 8 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 198.365 SH | 8 Agu 2026 | Harian |
| ISCV · iShares Trust | 0,07% | 6.414 SH | 8 Agu 2026 | Harian |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 151.830 NS | 31 Mei 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 11.131 NS | 30 April 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 1.294 SH | 8 Agu 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 387.471 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,03% | 92.340 SH | 8 Agu 2026 | Harian |
| WSML · iShares Trust | 0,02% | 1.887 SH | 8 Agu 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 3.096 SH | 8 Agu 2026 | Harian |
| IWN · iShares Trust | 0,02% | 32.466 SH | 8 Agu 2026 | Harian |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 6.903 NS | 31 Mei 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 48.124 SH | 8 Agu 2026 | Harian |
| IWV · iShares Trust | 0,00% | 9.139 SH | 8 Agu 2026 | Harian |
| TILT · FlexShares Trust | 0,00% | 770 NS | 30 April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 18.540 NS | 31 Mei 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.075.430 SH | 8 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.837 SH | 8 Agu 2026 | Harian |